Tuesday 13 October 2026
Export all NUS data to Excel Powerpack
Nu Skin Enterprises, Inc.
NUS Consumer Defensive Household & Personal Products
Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.87
0.13
+2.74%
Follow NUS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
5.52 | 2.97 | 6.50 | 0.00 |
P/S ratio |
0.39 | 0.32 | 0.24 | 0.19 | |
P/FCF ratio |
11.29 | 10.31 | 8.44 | 23.80 | |
P/Operating CF |
21.91 | 28.53 | (89.54) | 24.15 | |
P/B ratio |
0.75 | 0.59 | 0.44 | 0.47 | |
Price to Tangible BV |
0.90 | 0.70 | 0.52 | 0.51 | |
EV/Sales |
0.37 | 0.31 | 0.26 | 0.20 | |
EV/EBITDA |
12.78 | 3.89 | 2.88 | 7.04 | |
EV/Operating CF |
6.46 | 5.71 | 4.92 | 5.49 | |
EV/FCF |
10.84 | 9.97 | 9.00 | 25.87 | |
Quick Ratio |
1.19 | 1.06 | 0.95 | 0.94 | |
Current Ratio |
2.15 | 2.08 | 2.03 | 1.98 | |
Net Debt/EBITDA |
(0.71) | (0.43) | 1.42 | (0.48) | |
Debt/Assets |
16.08% | 15.95% | 16.24% | 19.05% | |
Debt/Equity |
0.29 | 0.28 | 0.28 | 0.39 | |
Asset Turnover |
1.04 | 1.03 | 1.04 | 1.07 | |
Operating CF/Net income |
1.61 | 1.15 | (2.13) | (0.04) | |
Capex/Depreciation |
(0.82) | (0.83) | (1.11) | (0.45) | |
Interest Coverage |
5.22 | 5.82 | 0.95 | (17.86) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
64.55% | 64.47% | 65.06% | 62.09% | |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.09 | 0.04 | |
Share Based Compensation of Revenue |
1.60% | 0.85% | 1.15% | 0.35% | |
Graham Net Nets |
(0.13) | (0.11) | (0.17) | (0.28) | |
Graham Number |
28.37 | 34.51 | 20.38 | 0.00 | |
Earnings Yield |
18.13% | 33.68% | 15.38% | (84.28%) | |
Free Cash Flow Yield |
8.86% | 9.70% | 11.85% | 4.20% | |
Revenue per Share |
7.37 | 7.51 | 6.65 | 6.59 | |
Operating CF per Share |
0.56 | 0.34 | (0.08) | 0.22 | |
Capex per Share |
(0.20) | (0.22) | (0.28) | (0.12) | |
Free Cash Flow per Share |
0.36 | 0.12 | (0.37) | 0.10 | |
Cash per Share |
5.12 | 4.87 | 4.16 | 3.94 | |
Shareholders Equity per Share |
16.19 | 16.34 | 16.47 | 11.17 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.19 | 16.34 | 16.47 | 11.17 | |
Free Cash Flow |
17.57 | 5.86 | (17.63) | 4.99 | |
Working Capital |
293.71 | 283.96 | 265.89 | 251.80 | |
Capital Expenditures |
(9.91) | (10.76) | (13.71) | (5.64) | |
Net Current Asset Value |
(76.47) | (52.37) | (59.82) | (70.64) | |
EV/EBIT |
0.00 | 6.97 | 4.69 | 0.00 | |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.02 | |
Price to Operating Income |
0.00 | 7.21 | 4.40 | 0.00 | |
| Other line items | |||||
Average Receivables |
58.85 | 45.16 | 50.79 | 54.30 | |
Average Payables |
30.63 | 30.53 | 31.20 | 33.22 | |
Average Inventory |
213.16 | 184.44 | 183.69 | 185.94 | |
Average Assets |
1,503.65 | 1,437.11 | 1,384.10 | 1,282.61 | |
Average Common Equity |
753.33 | 728.35 | 774.03 | 665.25 |
Columns are period end dates